Wills Financial Group Inc. acquired a new position in shares of Albemarle Co. (NYSE:ALB) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 1,740 shares of the specialty chemicals company’s stock, valued at approximately $237,000.

Several other large investors also recently modified their holdings of ALB. Vanguard Group Inc. boosted its stake in Albemarle by 1.7% during the second quarter. Vanguard Group Inc. now owns 12,501,329 shares of the specialty chemicals company’s stock worth $1,319,389,000 after acquiring an additional 213,530 shares in the last quarter. Jennison Associates LLC increased its holdings in Albemarle by 21.4% during the third quarter. Jennison Associates LLC now owns 7,797,076 shares of the specialty chemicals company’s stock worth $1,062,819,000 after buying an additional 1,375,546 shares during the last quarter. Bank of New York Mellon Corp increased its holdings in Albemarle by 258.1% during the third quarter. Bank of New York Mellon Corp now owns 4,561,987 shares of the specialty chemicals company’s stock worth $621,845,000 after buying an additional 3,287,989 shares during the last quarter. TIAA CREF Investment Management LLC boosted its position in Albemarle by 69.2% during the second quarter. TIAA CREF Investment Management LLC now owns 1,661,821 shares of the specialty chemicals company’s stock worth $175,389,000 after purchasing an additional 679,453 shares during the period. Finally, Allianz Asset Management GmbH lifted its position in Albemarle by 98.8% during the third quarter. Allianz Asset Management GmbH now owns 1,307,904 shares of the specialty chemicals company’s stock valued at $178,281,000 after purchasing an additional 650,158 shares during the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

Several research analysts have commented on the stock. BidaskClub downgraded shares of Albemarle from a “buy” rating to a “hold” rating in a research note on Saturday, August 12th. UBS boosted their target price on shares of Albemarle from $123.00 to $150.00 and gave the company a “neutral” rating in a report on Thursday, November 9th. Jefferies Group reiterated a “buy” rating on shares of Albemarle in a research note on Tuesday, October 24th. BMO Capital Markets assumed coverage on Albemarle in a research report on Tuesday, October 24th. They issued an “outperform” rating and a $160.00 target price for the company. Finally, Vertical Research reissued a “hold” rating and issued a $109.00 target price (up previously from $108.00) on shares of Albemarle in a research report on Thursday, August 10th. Ten research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $128.45.

Albemarle Co. (NYSE:ALB) opened at $129.08 on Friday. The company has a quick ratio of 1.56, a current ratio of 2.11 and a debt-to-equity ratio of 0.35. Albemarle Co. has a one year low of $85.60 and a one year high of $144.99. The company has a market cap of $14,085.98, a price-to-earnings ratio of 31.55, a P/E/G ratio of 1.93 and a beta of 1.69.

Albemarle (NYSE:ALB) last announced its earnings results on Wednesday, November 8th. The specialty chemicals company reported $1.08 EPS for the quarter, beating the Zacks’ consensus estimate of $1.07 by $0.01. The firm had revenue of $755.00 million for the quarter, compared to analysts’ expectations of $732.19 million. Albemarle had a net margin of 30.07% and a return on equity of 11.61%. The company’s quarterly revenue was up 15.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.91 EPS. analysts anticipate that Albemarle Co. will post 4.46 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, January 2nd. Investors of record on Friday, December 15th will be given a $0.32 dividend. The ex-dividend date is Thursday, December 14th. This represents a $1.28 dividend on an annualized basis and a yield of 0.99%. Albemarle’s dividend payout ratio is presently 16.56%.

COPYRIGHT VIOLATION NOTICE: “Wills Financial Group Inc. Purchases New Stake in Albemarle Co. (ALB)” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece on another domain, it was illegally copied and reposted in violation of US and international trademark & copyright law. The legal version of this piece can be read at https://www.thecerbatgem.com/2017/12/08/wills-financial-group-inc-purchases-new-stake-in-albemarle-co-alb.html.

Albemarle Company Profile

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

Institutional Ownership by Quarter for Albemarle (NYSE:ALB)

Receive News & Stock Ratings for Albemarle Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle Co. and related stocks with our FREE daily email newsletter.